Actinium Pharmaceuticals
$1.0300
69
+$0.02+1.98% 17:28 Today
Statistics
Day High
1.05
Day Low
1.01
52W High
1.8
52W Low
0.735
Volume
54,802
Avg. Volume
141,880
Mkt Cap
32.32M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
23NovExpected
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.51
-0.04
0.42
0.89
Expected EPS
-0.255
Actual EPS
N/A
Financials
-37,652.22%Profit Margin
Unprofitable90,000Revenue
-33.89MNet Income
Analyst Ratings
5.00Average Price Target
The highest estimate is 5.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow ATNM. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Celldex Therapeutics
CLDX
Mkt Cap3.17B
Gilead Sciences
GILD
Mkt Cap181.18B
Incyte
INCY
Mkt Cap25.91B
Karyopharm Therapeutics
KPTI
Mkt Cap44.46M
Novartis
NVS
Mkt Cap301.95B
About
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of targeted radiotherapies using its Antibody Radiation Conjugates (ARCs) platform, which combines monoclonal antibodies with radioisotopes to selectively target and destroy cancer cells. The company's product candidates include Iomab-B, an iodine-131 based radiotherapy for conditioning prior to hematopoietic stem cell transplantation, and Actimab-A, an actinium-225 based radiotherapy in clinical development for acute myeloid leukemia. The company is also advancing additional programs, including Iomab-ACT for cell and gene therapy conditioning and other preclinical candidates targeting solid tumors.
Show more...
CEO
Sandesh C. Seth
Employees
25
Country
United States
ISIN
US00507W2061
WKN
000A2QA48
Listings
0 Comments
Share your thoughts
FAQ
What is Actinium Pharmaceuticals stock price today?▼
The current price of ATNM is $1.03 USD — it has increased by +1.98% in the past 24 hours. Watch Actinium Pharmaceuticals stock price performance more closely on the chart.
What is Actinium Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XASE exchange Actinium Pharmaceuticals stocks are traded under the ticker ATNM.
Is Actinium Pharmaceuticals stock price growing?▼
ATNM stock has fallen by -8.93% compared to the previous week, the month change is a +19.38% rise, over the last year Actinium Pharmaceuticals has showed a -42.05% decrease.
What is Actinium Pharmaceuticals market cap?▼
Today Actinium Pharmaceuticals has the market capitalization of 32.32M
When is the next Actinium Pharmaceuticals earnings date?▼
Actinium Pharmaceuticals is going to release the next earnings report on November 23, 2026.
What is Actinium Pharmaceuticals revenue for the last year?▼
Actinium Pharmaceuticals revenue for the last year amounts to 90,000 USD.
What is Actinium Pharmaceuticals net income for the last year?▼
ATNM net income for the last year is -33.89M USD.
How many employees does Actinium Pharmaceuticals have?▼
As of August 27, 2026, the company has 25 employees.
In which sector is Actinium Pharmaceuticals located?▼
Actinium Pharmaceuticals operates in the Health & Wellness sector.
When did Actinium Pharmaceuticals complete a stock split?▼
The last stock split for Actinium Pharmaceuticals was on August 11, 2020 with a ratio of 1:30.
Where is Actinium Pharmaceuticals headquartered?▼
Actinium Pharmaceuticals is headquartered in NEW YORK, United States.